{
event: "article_read",
name: `BRIGHT study`,
author: `Sanofi`,
tags: `Diabetes`,
publication_date: ``,
interaction_type: "content"
}
- Article
- Source: Campus Sanofi
BRIGHT study
All relevant safety information about adverse reactions, precautions, and relevant contraindications can be found on the product page HERE.
BRIGHT study - summary
A summary of the BRIGHT study results. BRIGHT is a head-to-head trial, comparing Toujeo® Insulin Glargine 300U/ml with insulin degludec 100 units/mL.
Our Products
MAT-IE-2300498 (v2.0) Date of Preparation: March 2026
